HOW TO DETECT AND TRACK CHRONIC NEUROLOGIC SEQUELAE OF COVID-19? USE OF AUDITORY BRAINSTEM RESPONSES AND NEUROIMAGING FOR LONG-TERM PATIENT FOLLOW-UP.
Identifieur interne : 000821 ( Main/Exploration ); précédent : 000820; suivant : 000822HOW TO DETECT AND TRACK CHRONIC NEUROLOGIC SEQUELAE OF COVID-19? USE OF AUDITORY BRAINSTEM RESPONSES AND NEUROIMAGING FOR LONG-TERM PATIENT FOLLOW-UP.
Auteurs : Michael Ogier [France] ; Guillaume Andéol [France] ; Emmanuel Sagui [France] ; Gregory Dal Bo [France]Source :
- Brain, behavior, & immunity - health [ 2666-3546 ] ; 2020.
Abstract
This review intends to provide an overview of the current knowledge on neurologic sequelae of COVID-19 and their possible etiology, and, based on available data, proposes possible improvements in current medical care procedures. We conducted a thorough review of the scientific literature on neurologic manifestations of COVID-19, the neuroinvasive propensity of known coronaviruses (CoV) and their possible effects on brain structural and functional integrity. It appears that around one third of COVID-19 patients admitted to intensive care units (ICU) for respiratory difficulties exhibit neurologic symptoms. This may be due to progressive brain damage and dysfunction triggered by severe hypoxia and hypoxemia, heightened inflammation and SARS-CoV-2 dissemination into brain parenchyma, as suggested by current reports and analyses of previous CoV outbreaks. Viral invasion of the brain may particularly target and alter brainstem and thalamic functions and, consequently, result in sensorimotor dysfunctions and psychiatric disorders. Moreover, data collected from other structurally homologous CoV suggest that SARS-CoV-2 infection may lead to brain cell degeneration and demyelination similar to multiple sclerosis (MS). Hence, current evidence warrants further evaluation and long-term follow-up of possible neurologic sequelae in COVID-19 patients. It may be particularly relevant to evaluate brainstem integrity in recovered patients, as it is suspected that this cerebral area may particularly be dysfunctional following SARS-CoV-2 infection. Because CoV infection can potentially lead to chronic neuroinflammation and progressive demyelination, neuroimaging features and signs of MS may also be evaluated in the long term in recovered COVID-19 patients.
DOI: 10.1016/j.bbih.2020.100081
PubMed: 32427134
PubMed Central: PMC7227537
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">HOW TO DETECT AND TRACK CHRONIC NEUROLOGIC SEQUELAE OF COVID-19? USE OF AUDITORY BRAINSTEM RESPONSES AND NEUROIMAGING FOR LONG-TERM PATIENT FOLLOW-UP.</title><author><name sortKey="Ogier, Michael" sort="Ogier, Michael" uniqKey="Ogier M" first="Michael" last="Ogier">Michael Ogier</name><affiliation wicri:level="3"><nlm:affiliation>French Armed Forces Biomedical Research Institute, 1 place Valérie André, 91220, Brétigny sur Orge, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>French Armed Forces Biomedical Research Institute, 1 place Valérie André, 91220, Brétigny sur Orge</wicri:regionArea><placeName><region type="region" nuts="2">Île-de-France</region><settlement type="city">Brétigny sur Orge</settlement></placeName></affiliation></author><author><name sortKey="Andeol, Guillaume" sort="Andeol, Guillaume" uniqKey="Andeol G" first="Guillaume" last="Andéol">Guillaume Andéol</name><affiliation wicri:level="3"><nlm:affiliation>French Armed Forces Biomedical Research Institute, 1 place Valérie André, 91220, Brétigny sur Orge, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>French Armed Forces Biomedical Research Institute, 1 place Valérie André, 91220, Brétigny sur Orge</wicri:regionArea><placeName><region type="region" nuts="2">Île-de-France</region><settlement type="city">Brétigny sur Orge</settlement></placeName></affiliation></author><author><name sortKey="Sagui, Emmanuel" sort="Sagui, Emmanuel" uniqKey="Sagui E" first="Emmanuel" last="Sagui">Emmanuel Sagui</name><affiliation wicri:level="3"><nlm:affiliation>French Armed Forces Biomedical Research Institute, 1 place Valérie André, 91220, Brétigny sur Orge, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>French Armed Forces Biomedical Research Institute, 1 place Valérie André, 91220, Brétigny sur Orge</wicri:regionArea><placeName><region type="region" nuts="2">Île-de-France</region><settlement type="city">Brétigny sur Orge</settlement></placeName></affiliation><affiliation wicri:level="3"><nlm:affiliation>European Hospital of Marseille, 6 rue Désirée Clary, 13003, Marseille, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>European Hospital of Marseille, 6 rue Désirée Clary, 13003, Marseille</wicri:regionArea><placeName><region type="region" nuts="2">Provence-Alpes-Côte d'Azur</region><settlement type="city">Marseille</settlement></placeName></affiliation></author><author><name sortKey="Bo, Gregory Dal" sort="Bo, Gregory Dal" uniqKey="Bo G" first="Gregory Dal" last="Bo">Gregory Dal Bo</name><affiliation wicri:level="3"><nlm:affiliation>French Armed Forces Biomedical Research Institute, 1 place Valérie André, 91220, Brétigny sur Orge, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>French Armed Forces Biomedical Research Institute, 1 place Valérie André, 91220, Brétigny sur Orge</wicri:regionArea><placeName><region type="region" nuts="2">Île-de-France</region><settlement type="city">Brétigny sur Orge</settlement></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32427134</idno><idno type="pmid">32427134</idno><idno type="doi">10.1016/j.bbih.2020.100081</idno><idno type="pmc">PMC7227537</idno><idno type="wicri:Area/Main/Corpus">000865</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000865</idno><idno type="wicri:Area/Main/Curation">000865</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000865</idno><idno type="wicri:Area/Main/Exploration">000865</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">HOW TO DETECT AND TRACK CHRONIC NEUROLOGIC SEQUELAE OF COVID-19? USE OF AUDITORY BRAINSTEM RESPONSES AND NEUROIMAGING FOR LONG-TERM PATIENT FOLLOW-UP.</title><author><name sortKey="Ogier, Michael" sort="Ogier, Michael" uniqKey="Ogier M" first="Michael" last="Ogier">Michael Ogier</name><affiliation wicri:level="3"><nlm:affiliation>French Armed Forces Biomedical Research Institute, 1 place Valérie André, 91220, Brétigny sur Orge, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>French Armed Forces Biomedical Research Institute, 1 place Valérie André, 91220, Brétigny sur Orge</wicri:regionArea><placeName><region type="region" nuts="2">Île-de-France</region><settlement type="city">Brétigny sur Orge</settlement></placeName></affiliation></author><author><name sortKey="Andeol, Guillaume" sort="Andeol, Guillaume" uniqKey="Andeol G" first="Guillaume" last="Andéol">Guillaume Andéol</name><affiliation wicri:level="3"><nlm:affiliation>French Armed Forces Biomedical Research Institute, 1 place Valérie André, 91220, Brétigny sur Orge, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>French Armed Forces Biomedical Research Institute, 1 place Valérie André, 91220, Brétigny sur Orge</wicri:regionArea><placeName><region type="region" nuts="2">Île-de-France</region><settlement type="city">Brétigny sur Orge</settlement></placeName></affiliation></author><author><name sortKey="Sagui, Emmanuel" sort="Sagui, Emmanuel" uniqKey="Sagui E" first="Emmanuel" last="Sagui">Emmanuel Sagui</name><affiliation wicri:level="3"><nlm:affiliation>French Armed Forces Biomedical Research Institute, 1 place Valérie André, 91220, Brétigny sur Orge, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>French Armed Forces Biomedical Research Institute, 1 place Valérie André, 91220, Brétigny sur Orge</wicri:regionArea><placeName><region type="region" nuts="2">Île-de-France</region><settlement type="city">Brétigny sur Orge</settlement></placeName></affiliation><affiliation wicri:level="3"><nlm:affiliation>European Hospital of Marseille, 6 rue Désirée Clary, 13003, Marseille, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>European Hospital of Marseille, 6 rue Désirée Clary, 13003, Marseille</wicri:regionArea><placeName><region type="region" nuts="2">Provence-Alpes-Côte d'Azur</region><settlement type="city">Marseille</settlement></placeName></affiliation></author><author><name sortKey="Bo, Gregory Dal" sort="Bo, Gregory Dal" uniqKey="Bo G" first="Gregory Dal" last="Bo">Gregory Dal Bo</name><affiliation wicri:level="3"><nlm:affiliation>French Armed Forces Biomedical Research Institute, 1 place Valérie André, 91220, Brétigny sur Orge, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>French Armed Forces Biomedical Research Institute, 1 place Valérie André, 91220, Brétigny sur Orge</wicri:regionArea><placeName><region type="region" nuts="2">Île-de-France</region><settlement type="city">Brétigny sur Orge</settlement></placeName></affiliation></author></analytic><series><title level="j">Brain, behavior, & immunity - health</title><idno type="eISSN">2666-3546</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">This review intends to provide an overview of the current knowledge on neurologic sequelae of COVID-19 and their possible etiology, and, based on available data, proposes possible improvements in current medical care procedures. We conducted a thorough review of the scientific literature on neurologic manifestations of COVID-19, the neuroinvasive propensity of known coronaviruses (CoV) and their possible effects on brain structural and functional integrity. It appears that around one third of COVID-19 patients admitted to intensive care units (ICU) for respiratory difficulties exhibit neurologic symptoms. This may be due to progressive brain damage and dysfunction triggered by severe hypoxia and hypoxemia, heightened inflammation and SARS-CoV-2 dissemination into brain parenchyma, as suggested by current reports and analyses of previous CoV outbreaks. Viral invasion of the brain may particularly target and alter brainstem and thalamic functions and, consequently, result in sensorimotor dysfunctions and psychiatric disorders. Moreover, data collected from other structurally homologous CoV suggest that SARS-CoV-2 infection may lead to brain cell degeneration and demyelination similar to multiple sclerosis (MS). Hence, current evidence warrants further evaluation and long-term follow-up of possible neurologic sequelae in COVID-19 patients. It may be particularly relevant to evaluate brainstem integrity in recovered patients, as it is suspected that this cerebral area may particularly be dysfunctional following SARS-CoV-2 infection. Because CoV infection can potentially lead to chronic neuroinflammation and progressive demyelination, neuroimaging features and signs of MS may also be evaluated in the long term in recovered COVID-19 patients.</div></front></TEI><pubmed><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">32427134</PMID><DateRevised><Year>2020</Year><Month>07</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2666-3546</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2020</Year><Month>May</Month><Day>15</Day></PubDate></JournalIssue><Title>Brain, behavior, & immunity - health</Title><ISOAbbreviation>Brain Behav Immun Health</ISOAbbreviation></Journal><ArticleTitle>HOW TO DETECT AND TRACK CHRONIC NEUROLOGIC SEQUELAE OF COVID-19? USE OF AUDITORY BRAINSTEM RESPONSES AND NEUROIMAGING FOR LONG-TERM PATIENT FOLLOW-UP.</ArticleTitle><Pagination><MedlinePgn>100081</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bbih.2020.100081</ELocationID><Abstract><AbstractText>This review intends to provide an overview of the current knowledge on neurologic sequelae of COVID-19 and their possible etiology, and, based on available data, proposes possible improvements in current medical care procedures. We conducted a thorough review of the scientific literature on neurologic manifestations of COVID-19, the neuroinvasive propensity of known coronaviruses (CoV) and their possible effects on brain structural and functional integrity. It appears that around one third of COVID-19 patients admitted to intensive care units (ICU) for respiratory difficulties exhibit neurologic symptoms. This may be due to progressive brain damage and dysfunction triggered by severe hypoxia and hypoxemia, heightened inflammation and SARS-CoV-2 dissemination into brain parenchyma, as suggested by current reports and analyses of previous CoV outbreaks. Viral invasion of the brain may particularly target and alter brainstem and thalamic functions and, consequently, result in sensorimotor dysfunctions and psychiatric disorders. Moreover, data collected from other structurally homologous CoV suggest that SARS-CoV-2 infection may lead to brain cell degeneration and demyelination similar to multiple sclerosis (MS). Hence, current evidence warrants further evaluation and long-term follow-up of possible neurologic sequelae in COVID-19 patients. It may be particularly relevant to evaluate brainstem integrity in recovered patients, as it is suspected that this cerebral area may particularly be dysfunctional following SARS-CoV-2 infection. Because CoV infection can potentially lead to chronic neuroinflammation and progressive demyelination, neuroimaging features and signs of MS may also be evaluated in the long term in recovered COVID-19 patients.</AbstractText><CopyrightInformation>© 2020 Published by Elsevier Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ogier</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>French Armed Forces Biomedical Research Institute, 1 place Valérie André, 91220, Brétigny sur Orge, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andéol</LastName><ForeName>Guillaume</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>French Armed Forces Biomedical Research Institute, 1 place Valérie André, 91220, Brétigny sur Orge, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sagui</LastName><ForeName>Emmanuel</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>French Armed Forces Biomedical Research Institute, 1 place Valérie André, 91220, Brétigny sur Orge, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>European Hospital of Marseille, 6 rue Désirée Clary, 13003, Marseille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bo</LastName><ForeName>Gregory Dal</ForeName><Initials>GD</Initials><AffiliationInfo><Affiliation>French Armed Forces Biomedical Research Institute, 1 place Valérie André, 91220, Brétigny sur Orge, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>05</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Brain Behav Immun Health</MedlineTA><NlmUniqueID>101759062</NlmUniqueID><ISSNLinking>2666-3546</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Auditory brainstem responses</Keyword><Keyword MajorTopicYN="N">Brainstem dysfunction</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Cytokine storm</Keyword><Keyword MajorTopicYN="N">Microglia priming</Keyword><Keyword MajorTopicYN="N">Multiple sclerosis</Keyword><Keyword MajorTopicYN="N">Neuroimaging</Keyword><Keyword MajorTopicYN="N">Neuroinflammatory mechanisms</Keyword><Keyword MajorTopicYN="N">Neurologic sequelae</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList><CoiStatement>none.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>05</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>05</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>5</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>5</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>5</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32427134</ArticleId><ArticleId IdType="doi">10.1016/j.bbih.2020.100081</ArticleId><ArticleId IdType="pii">S2666-3546(20)30046-6</ArticleId><ArticleId IdType="pii">100081</ArticleId><ArticleId IdType="pmc">PMC7227537</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Med Virol. 2020 Jun;92(6):552-555</Citation><ArticleIdList><ArticleId IdType="pubmed">32104915</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuropharmacology. 2015 Sep;96(Pt A):29-41</Citation><ArticleIdList><ArticleId IdType="pubmed">25445485</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurocrit Care. 2017 Feb;26(1):143-156</Citation><ArticleIdList><ArticleId IdType="pubmed">27484878</ArticleId></ArticleIdList></Reference><Reference><Citation>J Med Virol. 2020 Jul;92(7):699-702</Citation><ArticleIdList><ArticleId IdType="pubmed">32314810</ArticleId></ArticleIdList></Reference><Reference><Citation>Trends Hear. 2017 Jan-Dec;21:2331216517737230</Citation><ArticleIdList><ArticleId IdType="pubmed">29090641</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Invest. 2018 Mar 1;128(3):931-943</Citation><ArticleIdList><ArticleId IdType="pubmed">29376888</ArticleId></ArticleIdList></Reference><Reference><Citation>J Thromb Haemost. 2020 May;18(5):1094-1099</Citation><ArticleIdList><ArticleId IdType="pubmed">32220112</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Neurol. 2003 May;60(5):667-71</Citation><ArticleIdList><ArticleId IdType="pubmed">12756129</ArticleId></ArticleIdList></Reference><Reference><Citation>Intervirology. 2016;59(3):163-169</Citation><ArticleIdList><ArticleId IdType="pubmed">28103598</ArticleId></ArticleIdList></Reference><Reference><Citation>Handb Clin Neurol. 2015;129:649-65</Citation><ArticleIdList><ArticleId IdType="pubmed">25726295</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Vet Res. 1980 Sep;41(9):1372-8</Citation><ArticleIdList><ArticleId IdType="pubmed">6255837</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurochem. 2008 Dec;107(6):1482-94</Citation><ArticleIdList><ArticleId IdType="pubmed">19014390</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Infect Dis. 2004 Feb;10(2):342-4</Citation><ArticleIdList><ArticleId IdType="pubmed">15030709</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Invest. 2020 May 1;130(5):2620-2629</Citation><ArticleIdList><ArticleId IdType="pubmed">32217835</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2020 Mar;579(7798):270-273</Citation><ArticleIdList><ArticleId IdType="pubmed">32015507</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Clin Pathol. 2020 May 5;153(6):725-733</Citation><ArticleIdList><ArticleId IdType="pubmed">32275742</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2015 Dec 23;10(12):e0145561</Citation><ArticleIdList><ArticleId IdType="pubmed">26701103</ArticleId></ArticleIdList></Reference><Reference><Citation>Compr Physiol. 2014 Oct;4(4):1339-68</Citation><ArticleIdList><ArticleId IdType="pubmed">25428846</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Transl Imaging. 2015;3:475-489</Citation><ArticleIdList><ArticleId IdType="pubmed">26705534</ArticleId></ArticleIdList></Reference><Reference><Citation>Viruses. 2013 Feb 15;5(2):732-52</Citation><ArticleIdList><ArticleId IdType="pubmed">23435240</ArticleId></ArticleIdList></Reference><Reference><Citation>FEBS Lett. 2002 Dec 4;532(1-2):107-10</Citation><ArticleIdList><ArticleId IdType="pubmed">12459472</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Neurosci. 2007 Nov;10(11):1387-94</Citation><ArticleIdList><ArticleId IdType="pubmed">17965659</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2020 Feb 20;382(8):727-733</Citation><ArticleIdList><ArticleId IdType="pubmed">31978945</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2015 Apr;89(7):3659-70</Citation><ArticleIdList><ArticleId IdType="pubmed">25589660</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2000 Oct;74(19):8913-21</Citation><ArticleIdList><ArticleId IdType="pubmed">10982334</ArticleId></ArticleIdList></Reference><Reference><Citation>Viruses. 2019 Dec 20;12(1):</Citation><ArticleIdList><ArticleId IdType="pubmed">31861926</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Audiol. 2009 Apr;48(4):161-71</Citation><ArticleIdList><ArticleId IdType="pubmed">19085395</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain Behav Immun. 2018 Oct;73:133-148</Citation><ArticleIdList><ArticleId IdType="pubmed">30009999</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2008 Aug;82(15):7264-75</Citation><ArticleIdList><ArticleId IdType="pubmed">18495771</ArticleId></ArticleIdList></Reference><Reference><Citation>Vet Pathol. 2004 Mar;41(2):101-7</Citation><ArticleIdList><ArticleId IdType="pubmed">15017022</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Arch Otorhinolaryngol. 2020 Aug;277(8):2251-2261</Citation><ArticleIdList><ArticleId IdType="pubmed">32253535</ArticleId></ArticleIdList></Reference><Reference><Citation>Annu Rev Immunol. 2009;27:119-45</Citation><ArticleIdList><ArticleId IdType="pubmed">19302036</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 2018 Nov 20;91(21):958-966</Citation><ArticleIdList><ArticleId IdType="pubmed">30355703</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Med. 1997 Nov 24;103(5A):40S-43S</Citation><ArticleIdList><ArticleId IdType="pubmed">9422621</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2015 Oct 07;90(1):57-67</Citation><ArticleIdList><ArticleId IdType="pubmed">26446606</ArticleId></ArticleIdList></Reference><Reference><Citation>J Exp Med. 2005 Aug 1;202(3):415-24</Citation><ArticleIdList><ArticleId IdType="pubmed">16043521</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2005 Oct 15;41(8):1089-96</Citation><ArticleIdList><ArticleId IdType="pubmed">16163626</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Physiol Regul Integr Comp Physiol. 2007 Jan;292(1):R373-81</Citation><ArticleIdList><ArticleId IdType="pubmed">16946085</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain. 1994 Oct;117 ( Pt 5):1127-41</Citation><ArticleIdList><ArticleId IdType="pubmed">7953594</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain Behav Immun. 2020 Jul;87:34-39</Citation><ArticleIdList><ArticleId IdType="pubmed">32298803</ArticleId></ArticleIdList></Reference><Reference><Citation>Viral Immunol. 2019 Jan/Feb;32(1):25-37</Citation><ArticleIdList><ArticleId IdType="pubmed">30109979</ArticleId></ArticleIdList></Reference><Reference><Citation>Philos Trans R Soc Lond B Biol Sci. 2009 Sep 12;364(1529):2447-51</Citation><ArticleIdList><ArticleId IdType="pubmed">19651646</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2016 Mar 1;213(5):712-22</Citation><ArticleIdList><ArticleId IdType="pubmed">26486634</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pathol. 2004 Jun;203(2):631-7</Citation><ArticleIdList><ArticleId IdType="pubmed">15141377</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Mol Neurosci. 2018 Jan 04;10:421</Citation><ArticleIdList><ArticleId IdType="pubmed">29354029</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Radiol. 2016 Jul;89(1063):20160004</Citation><ArticleIdList><ArticleId IdType="pubmed">27226217</ArticleId></ArticleIdList></Reference><Reference><Citation>Virus Res. 2008 Apr;133(1):4-12</Citation><ArticleIdList><ArticleId IdType="pubmed">17825937</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 1980 Aug 22;209(4459):933-4</Citation><ArticleIdList><ArticleId IdType="pubmed">7403860</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2020 Mar 26;368:m1091</Citation><ArticleIdList><ArticleId IdType="pubmed">32217556</ArticleId></ArticleIdList></Reference><Reference><Citation>Handb Clin Neurol. 2017;140:33-48</Citation><ArticleIdList><ArticleId IdType="pubmed">28187807</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2020 Jun 4;382(23):2268-2270</Citation><ArticleIdList><ArticleId IdType="pubmed">32294339</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2007 Jan;81(2):813-21</Citation><ArticleIdList><ArticleId IdType="pubmed">17079315</ArticleId></ArticleIdList></Reference><Reference><Citation>Handb Clin Neurol. 2015;129:509-36</Citation><ArticleIdList><ArticleId IdType="pubmed">25726288</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Infect Dis. 2020 May;94:55-58</Citation><ArticleIdList><ArticleId IdType="pubmed">32251791</ArticleId></ArticleIdList></Reference><Reference><Citation>Radiology. 2020 Mar 31;:201187</Citation><ArticleIdList><ArticleId IdType="pubmed">32228363</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2020 Feb 15;395(10223):497-506</Citation><ArticleIdList><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain Behav Immun. 2020 Jul;87:18-22</Citation><ArticleIdList><ArticleId IdType="pubmed">32240762</ArticleId></ArticleIdList></Reference><Reference><Citation>Infection. 2015 Aug;43(4):495-501</Citation><ArticleIdList><ArticleId IdType="pubmed">25600929</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Neurol. 2017 Jul;13(3):227-233</Citation><ArticleIdList><ArticleId IdType="pubmed">28748673</ArticleId></ArticleIdList></Reference><Reference><Citation>Hear Res. 1995 Jan;82(1):109-24</Citation><ArticleIdList><ArticleId IdType="pubmed">7744707</ArticleId></ArticleIdList></Reference><Reference><Citation>Radiology. 2020 Apr;295(1):20</Citation><ArticleIdList><ArticleId IdType="pubmed">32032497</ArticleId></ArticleIdList></Reference><Reference><Citation>Virology. 2013 Dec;447(1-2):112-20</Citation><ArticleIdList><ArticleId IdType="pubmed">24210105</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA Neurol. 2020 Apr 10;:</Citation><ArticleIdList><ArticleId IdType="pubmed">32275288</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Mol Sci. 2019 Jun 28;20(13):</Citation><ArticleIdList><ArticleId IdType="pubmed">31261683</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2020 Apr 16;181(2):271-280.e8</Citation><ArticleIdList><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Hear Res. 2000 May;143(1-2):29-42</Citation><ArticleIdList><ArticleId IdType="pubmed">10771182</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Dev Immunol. 2013;2013:510396</Citation><ArticleIdList><ArticleId IdType="pubmed">23864878</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2004 Aug;78(16):8824-34</Citation><ArticleIdList><ArticleId IdType="pubmed">15280490</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>France</li></country><region><li>Provence-Alpes-Côte d'Azur</li><li>Île-de-France</li></region><settlement><li>Brétigny sur Orge</li><li>Marseille</li></settlement></list><tree><country name="France"><region name="Île-de-France"><name sortKey="Ogier, Michael" sort="Ogier, Michael" uniqKey="Ogier M" first="Michael" last="Ogier">Michael Ogier</name></region><name sortKey="Andeol, Guillaume" sort="Andeol, Guillaume" uniqKey="Andeol G" first="Guillaume" last="Andéol">Guillaume Andéol</name><name sortKey="Bo, Gregory Dal" sort="Bo, Gregory Dal" uniqKey="Bo G" first="Gregory Dal" last="Bo">Gregory Dal Bo</name><name sortKey="Sagui, Emmanuel" sort="Sagui, Emmanuel" uniqKey="Sagui E" first="Emmanuel" last="Sagui">Emmanuel Sagui</name><name sortKey="Sagui, Emmanuel" sort="Sagui, Emmanuel" uniqKey="Sagui E" first="Emmanuel" last="Sagui">Emmanuel Sagui</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidPsychoV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000821 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000821 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidPsychoV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:32427134
|texte= HOW TO DETECT AND TRACK CHRONIC NEUROLOGIC SEQUELAE OF COVID-19? USE OF AUDITORY BRAINSTEM RESPONSES AND NEUROIMAGING FOR LONG-TERM PATIENT FOLLOW-UP.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32427134" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a CovidPsychoV1
| This area was generated with Dilib version V0.6.35. |  |